Fluorescent dye to guide bladder tumor removal
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a special fluorescent dye (given before surgery) can make bladder tumor removal more precise by helping the surgeon see exactly where the tumor is during the operation. It aims to reduce the chance of leaving cancerous tissue behind.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old
- You must be scheduled for a surgery to remove a bladder tumor through the urethra
- You cannot have any other type of cancer
- You cannot have had a heart attack or stroke in the last 6 months, or have severe liver or kidney disease
- You cannot be pregnant, breastfeeding, or allergic to drugs or food
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy and immunotherapy to treat large, non-invasive bladder cancer before and after surgery. It aims to avoid removing the bladder while still effectively treating the cancer.
This trial tests a special dye that binds to bladder cancer cells and makes them glow during surgery. It may help doctors find and remove the cancer more completely.
This trial tests a special imaging dye that lights up bladder cancer during surgery, helping doctors see and remove it more precisely. It may help ensure all cancer is removed while sparing healthy tissue.
This study tests whether using a special blue light (photodynamic diagnosis) during bladder surgery helps remove all the cancer more completely. It's for people having their first surgery for a medium-sized bladder tumor.
This Phase 2 study tests a treatment called photodynamic therapy (PDT) placed directly into the bladder. It may help people whose non–muscle-invasive bladder cancer did not respond to BCG treatment or could not tolerate it.
This trial tests whether artificial intelligence (AI) can help guide surgeons during a procedure called TURBT to remove early-stage bladder cancer. The goal is to see if this technology improves the removal of cancer while potentially reducing risks.
Hear when a new NMIBC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.